Sunshine Biopharma, Inc. (SBFM)
Develops cancer drugs and antivirals while selling generic medications and supplements.
$1.43-0.07%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-89.9%
The outlook
SBFM trades at $1.43, sitting near its 52-week low with price below both its 50- and 200-day moving averages. Analyst coverage shows an average price target roughly 38x higher than the current price, though this reflects sparse research on a micro-cap biotech stock. The overall StockGlow score leans bearish at 19/100.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +3816% vs current price
Market cap
$3.0M
52-wk high
$24.30
52-wk low
$1.41
50-day avg
$2.47
200-day avg
$10.34
Trailing P/E
—